European equities traded in the US as American depositary receipts plunged late Monday morning, tumbling 2.5% to 1,357.86 on the S&P Europe Select ADR Index.
From continental Europe, the only gainers were biopharmaceutical companies MorphoSys (MOR) and Calliditas Therapeutics (CALT), which rose 2.4% and 1.3% respectively.
The decliners from continental Europe were led by biotech firm Evaxion Biotech (EVAX) and 3D printer company Materialise (MTLS), which fell 11.4% and 6.7% respectively. They were followed by accommodation booking site trivago (TRVG) and biotech firm BioNTech (BNTX), which lost 6.3% and 6.2% respectively.
From the UK and Ireland, the only gainers were biopharmaceutical companies NuCana (NCNA) and TC Biopharm, which were up 1.7% and 0.4% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies Adaptimmune Therapeutics (ADAP) and Bicycle Therapeutics (BCYC), which tumbled 12.4% and 10% respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Verona Pharma (VRNA), which dropped 9.6% and 6.7% respectively.
Comments